National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England
Estimated value
—
Awarded value
—
Suppliers
93
Lots
49
Published
28 Apr 2021
Description
NHS National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England. Period of framework agreement: 1 April 2021 to 31 March 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.
Scope
- Reference
- ocds-h6vhtk-02ab4a
- Commercial tool
- Standalone contract
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 93 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 49 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 25 | Fluorouracil in Elastomeric Devices (Autofuser 2ml/hr) - Lot 25 | — | cancelled |
| 22 | Fluorouracil in Elastomeric Devices (Folfusor LV1.5) - Lot 22 | — | cancelled |
| 1 | Atezolizumab - Lot 1 | — | cancelled |
| 2 | Bevacizumab (Avastin) - Lot 2 | — | cancelled |
| 3 | Bevacizumab (Zirabev) - Lot 3 | — | cancelled |
Award 1· 1 supplier
Awarded —
Award 2· 1 supplier
Awarded —
Award 3· 1 supplier
Awarded —
Award 4· 1 supplier
Awarded —
Award 5· 1 supplier
Awarded —
Award 6· 1 supplier
Awarded —
Award 7· 1 supplier
Awarded —
Award 8· 1 supplier
Awarded —
Award 9· 1 supplier
Awarded —
Award 10· 1 supplier
Awarded —
Award 11· 1 supplier
Awarded —
Award 12· 1 supplier
Awarded —
Award 13· 1 supplier
Awarded —
Award 14· 1 supplier
Awarded —
Award 15· 1 supplier
Awarded —
Award 16· 1 supplier
Awarded —
Award 17· 1 supplier
Awarded —
Award 18· 1 supplier
Awarded —
Award 19· 1 supplier
Awarded —
Award 20· 1 supplier
Awarded —
Award 21· 1 supplier
Awarded —
Award 22· 1 supplier
Awarded —
Award 23· 1 supplier
Awarded —
Award 24· 1 supplier
Awarded —
Award 25· 1 supplier
Awarded —
Award 26· 1 supplier
Awarded —
Award 27· 1 supplier
Awarded —
Award 28· 1 supplier
Awarded —
Award 29· 1 supplier
Awarded —
Award 30· 1 supplier
Awarded —
Award 31· 1 supplier
Awarded —
Award 32· 1 supplier
Awarded —
Award 33· 1 supplier
Awarded —
Award 34· 1 supplier
Awarded —
Award 35· 1 supplier
Awarded —
Award 36· 1 supplier
Awarded —
Award 37· 1 supplier
Awarded —
Award 38· 1 supplier
Awarded —
Award 39· 1 supplier
Awarded —
Award 40· 1 supplier
Awarded —
Award 41· 1 supplier
Awarded —
Award 42· 1 supplier
Awarded —
Award 43· 1 supplier
Awarded —
Award 44· 1 supplier
Awarded —
Award 45· 1 supplier
Awarded —
Award 46· 1 supplier
Awarded —
Award 47· 1 supplier
Awarded —
Award 48· 1 supplier
Awarded —
Award 49· 1 supplier
Awarded —
Award 50· 1 supplier
Awarded —
Award 51· 1 supplier
Awarded —
Award 52· 1 supplier
Awarded —
Award 53· 1 supplier
Awarded —
Award 54· 1 supplier
Awarded —
Award 55· 1 supplier
Awarded —
Award 56· 1 supplier
Awarded —
Award 57· 1 supplier
Awarded —
Award 58· 1 supplier
Awarded —
Award 59· 1 supplier
Awarded —
Award 60· 1 supplier
Awarded —
Award 61· 1 supplier
Awarded —
Award 62· 1 supplier
Awarded —
Award 63· 1 supplier
Awarded —
Award 64· 1 supplier
Awarded —
Award 65· 1 supplier
Awarded —
Award 66· 1 supplier
Awarded —
Award 67· 1 supplier
Awarded —
Award 68· 1 supplier
Awarded —
Award 69· 1 supplier
Awarded —
Award 70· 1 supplier
Awarded —
Award 71· 1 supplier
Awarded —
Award 72· 1 supplier
Awarded —
Award 73· 1 supplier
Awarded —
Award 74· 1 supplier
Awarded —
Award 75· 1 supplier
Awarded —
Award 76· 1 supplier
Awarded —
Award 77· 1 supplier
Awarded —
Award 78· 1 supplier
Awarded —
Award 79· 1 supplier
Awarded —
Award 80· 1 supplier
Awarded —
Award 81· 1 supplier
Awarded —
Award 82· 1 supplier
Awarded —
Award 83· 1 supplier
Awarded —
Award 84· 1 supplier
Awarded —
Award 85· 1 supplier
Awarded —
Award 86· 1 supplier
Awarded —
Award 87· 1 supplier
Awarded —
Award 88· 1 supplier
Awarded —
Award 89· 1 supplier
Awarded —
Award 90· 1 supplier
Awarded —
Award 91· 1 supplier
Awarded —
Award 92· 1 supplier
Awarded —
Award 93· 1 supplier
Awarded —
Total lots
49
Awarded
49
Estimated total
—
Awarded total
—
Fluorouracil in Elastomeric Devices (Autofuser 2ml/hr) - Lot 25
Start
—
End
—
Estimated
—
CPV
Fluorouracil in Elastomeric Devices (Folfusor LV1.5) - Lot 22
Start
—
End
—
Estimated
—
CPV
Atezolizumab - Lot 1
Start
—
End
—
Estimated
—
CPV
Bevacizumab (Avastin) - Lot 2
Start
—
End
—
Estimated
—
CPV
Bevacizumab (Zirabev) - Lot 3
Start
—
End
—
Estimated
—
CPV
Bevacizumab (Aybintio) - Lot 4
Start
—
End
—
Estimated
—
CPV
Bleomycin - Lot 5
Start
—
End
—
Estimated
—
CPV
Cyclophosphamide Bags - Lot 11
Start
—
End
—
Estimated
—
CPV
Obinutuzumab - Lot 33
Start
—
End
—
Estimated
—
CPV
Pemetrexed - Lot 38
Start
—
End
—
Estimated
—
CPV
Fludarabine Bags - Lot 17
Start
—
End
—
Estimated
—
CPV
Ganciclovir - Lot 27
Start
—
End
—
Estimated
—
CPV
Methotrexate - Lot 31
Start
—
End
—
Estimated
—
CPV
Fluorouracil in Elastomeric Devices (Folfusor LV5) - Lot 23
Start
—
End
—
Estimated
—
CPV
Fluorouracil Bags - Lot 19
Start
—
End
—
Estimated
—
CPV
Bortezomib - Lot 6
Start
—
End
—
Estimated
—
CPV
Pertuzumab - Lot 39
Start
—
End
—
Estimated
—
CPV
Carboplatin - Lot 7
Start
—
End
—
Estimated
—
CPV
Panitumumab - Lot 36
Start
—
End
—
Estimated
—
CPV
Vinorelbine - Lot 50
Start
—
End
—
Estimated
—
CPV
Fluorouracil in Elastomeric Devices (Folfusor SV2.5) - Lot 21
Start
—
End
—
Estimated
—
CPV
Irinotecan - Lot 30
Start
—
End
—
Estimated
—
CPV
Fludarabine Syringes - Lot 16
Start
—
End
—
Estimated
—
CPV
Trastuzumab (Trasimera) - Lot 47
Start
—
End
—
Estimated
—
CPV
Fluorouracil in Elastomeric Devices (Autofuser 2.5ml/hr) - Lot 24
Start
—
End
—
Estimated
—
CPV
Pembrolizumab - Lot 37
Start
—
End
—
Estimated
—
CPV
Cetuximab - Lot 8
Start
—
End
—
Estimated
—
CPV
Docetaxel - Lot 13
Start
—
End
—
Estimated
—
CPV
Fluorouracil Syringes - Lot 18
Start
—
End
—
Estimated
—
CPV
Doxorubicin - Lot 14
Start
—
End
—
Estimated
—
CPV
Fluorouracil in Elastomeric Devices (Surefuser) - Lot 26
Start
—
End
—
Estimated
—
CPV
Cytarabine - Lot 12
Start
—
End
—
Estimated
—
CPV
Nivolumab - Lot 32
Start
—
End
—
Estimated
—
CPV
Cyclophosphamide Syringes - Lot 10
Start
—
End
—
Estimated
—
CPV
Trastuzumab (Herzuma) - Lot 44
Start
—
End
—
Estimated
—
CPV
Oxaliplatin - Lot 34
Start
—
End
—
Estimated
—
CPV
Vinblastine - Lot 48
Start
—
End
—
Estimated
—
CPV
Cisplatin - Lot 9
Start
—
End
—
Estimated
—
CPV
Gemcitabine - Lot 28
Start
—
End
—
Estimated
—
CPV
Vincristine - Lot 49
Start
—
End
—
Estimated
—
CPV
Trastuzumab (Herceptin) - Lot 43
Start
—
End
—
Estimated
—
CPV
Trastuzumab (Ontruzant) - Lot 46
Start
—
End
—
Estimated
—
CPV
Epirubicin - Lot 15
Start
—
End
—
Estimated
—
CPV
Rituximab (Truxima) - Lot 42
Start
—
End
—
Estimated
—
CPV
Rituximab (Mabthera) - Lot 40
Start
—
End
—
Estimated
—
CPV
Rituximab (Rixathon) - Lot 41
Start
—
End
—
Estimated
—
CPV
Paclitaxel - Lot 35
Start
—
End
—
Estimated
—
CPV
Trastuzumab (Kanjinti) - Lot 45
Start
—
End
—
Estimated
—
CPV
Fluorouracil in Elastomeric Devices (Folfusor SV0.5) - Lot 20
Start
—
End
—
Estimated
—
CPV
Other contracts from The NHS Commissioning Board (operating under the name of NHS England)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Qualasept Ltd t/a Bath ASU· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Framework Agreement for the Provision of Dose Banded Chemotherapy Services | contract | £3.0m | 22 Jun 2026 |
| Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services | contract | — | 07 Apr 2026 |
| Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services | contract | — | 26 Jan 2026 |
| Framework for the supply of Ready to Administer Products | contract | — | 23 Oct 2025 |
| Supply of Nonchemotherapy Compounded Monoclonal Antibodies | contract | — | 06 Oct 2025 |
| Framework for the supply of Ready to Administer Products | contract | — | 22 Sept 2025 |
| D105 - Ready to Administer Products | contract | — | 20 Aug 2025 |
| Aseptically Manipulated or Terminally Sterile Medicinal Products | contract | — | 20 Aug 2024 |
| Aseptically Manipulated or Terminally Sterile Medicinal Products Framework (Lot 5) | contract | — | 20 Aug 2024 |
| Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) | contract | — | 09 Aug 2024 |